87,500 Shares in Avantor, Inc. $AVTR Acquired by EFG International AG

EFG International AG purchased a new position in shares of Avantor, Inc. (NYSE:AVTR) during the second quarter, HoldingsChannel.com reports. The fund purchased 87,500 shares of the company’s stock, valued at approximately $866,000.

A number of other hedge funds also recently made changes to their positions in AVTR. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its stake in shares of Avantor by 28.1% during the 3rd quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 4,123 shares of the company’s stock valued at $49,000 after buying an additional 905 shares during the period. Osaic Holdings Inc. raised its position in shares of Avantor by 60.9% in the 2nd quarter. Osaic Holdings Inc. now owns 2,810 shares of the company’s stock worth $38,000 after buying an additional 1,064 shares during the period. UMB Bank n.a. raised its position in shares of Avantor by 17.6% in the 4th quarter. UMB Bank n.a. now owns 7,371 shares of the company’s stock worth $84,000 after buying an additional 1,101 shares during the period. EverSource Wealth Advisors LLC boosted its holdings in Avantor by 119.1% in the second quarter. EverSource Wealth Advisors LLC now owns 2,187 shares of the company’s stock valued at $29,000 after acquiring an additional 1,189 shares during the last quarter. Finally, Public Employees Retirement System of Ohio boosted its holdings in Avantor by 0.6% in the third quarter. Public Employees Retirement System of Ohio now owns 206,386 shares of the company’s stock valued at $2,576,000 after acquiring an additional 1,279 shares during the last quarter. Institutional investors and hedge funds own 95.08% of the company’s stock.

Avantor Trading Up 0.6%

AVTR opened at $14.59 on Friday. The firm has a market capitalization of $9.87 billion, a P/E ratio of -17.37, a P/E/G ratio of 10.94 and a beta of 0.89. The firm’s 50 day moving average is $12.02 and its 200-day moving average is $9.74. Avantor, Inc. has a 52-week low of $7.26 and a 52-week high of $15.93. The company has a quick ratio of 1.18, a current ratio of 1.78 and a debt-to-equity ratio of 0.65.

Avantor (NYSE:AVTR) last announced its earnings results on Wednesday, July 29th. The company reported $0.21 earnings per share for the quarter, beating the consensus estimate of $0.19 by $0.02. The business had revenue of $1.69 billion during the quarter, compared to the consensus estimate of $1.61 billion. Avantor had a negative net margin of 8.81% and a positive return on equity of 9.92%. The business’s quarterly revenue was up .5% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.24 earnings per share. Avantor has set its FY 2026 guidance at 0.800-0.830 EPS. Analysts expect that Avantor, Inc. will post 0.81 EPS for the current fiscal year.

Analysts Set New Price Targets

AVTR has been the subject of a number of research reports. Zacks Research raised Avantor from a “strong sell” rating to a “hold” rating in a research report on Thursday, April 30th. TD Cowen restated a “hold” rating on shares of Avantor in a report on Wednesday, July 15th. Jefferies Financial Group raised Avantor from an “underperform” rating to a “hold” rating and set a $13.00 price objective on the stock in a research note on Wednesday, July 29th. Deutsche Bank Aktiengesellschaft reissued a “hold” rating and issued a $13.00 target price on shares of Avantor in a research note on Thursday, July 30th. Finally, Wolfe Research upgraded shares of Avantor from a “strong sell” rating to a “hold” rating in a report on Thursday, July 30th. Two analysts have rated the stock with a Buy rating, fifteen have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, Avantor currently has a consensus rating of “Hold” and an average price target of $12.00.

Avantor Profile

Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.

Avantor’s offerings are organized across two primary segments.